Larvol Delta - uniQure-Announces-Dosing-of-First-Patient-in-Phase-III-Clinical-Trial-of-AMT162-for-the-Treatment-of-SOD1ALS

AMT-162 - uniQure

https://www.globenewswire.com/news-release/2024/10/15/2963063/0/en/uniQure-Announces-Dosing-of-First-Patient-in-Phase-I-II-Clinical-Trial-of-AMT-162-for-the-Treatment-of-SOD1-ALS.html

Oct 15, 2024

SHARE THIS

Print
Email
More sharing

Reddit

StumbleUpon

Delicious

Prev Next